AP NEWS

Analysis: Positioning to Benefit within China Biologic Products, Merus N.V, Adient, G1 Therapeutics, Westport Fuel, and AppFolio — Research Highlights Growth, Revenue, and Consolidated Results

June 6, 2018

NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of China Biologic Products, Inc. (NASDAQ:CBPO), Merus N.V. (NASDAQ:MRUS), Adient PLC (NYSE:ADNT), G1 Therapeutics, Inc. (NASDAQ:GTHX), Westport Fuel Systems Inc. (NASDAQ:WPRT), and AppFolio, Inc. (NASDAQ:APPF), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CBPO DOWNLOAD: http://Fundamental-Markets.com/register/?so=CBPO MRUS DOWNLOAD: http://Fundamental-Markets.com/register/?so=MRUS ADNT DOWNLOAD: http://Fundamental-Markets.com/register/?so=ADNT GTHX DOWNLOAD: http://Fundamental-Markets.com/register/?so=GTHX WPRT DOWNLOAD: http://Fundamental-Markets.com/register/?so=WPRT APPF DOWNLOAD: http://Fundamental-Markets.com/register/?so=APPF

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine China Biologic Products, Inc. (NASDAQ:CBPO), Merus N.V. (NASDAQ:MRUS), Adient PLC (NYSE:ADNT), G1 Therapeutics, Inc. (NASDAQ:GTHX), Westport Fuel Systems Inc. (NASDAQ:WPRT), and AppFolio, Inc. (NASDAQ:APPF) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 4th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CHINA BIOLOGIC PRODUCTS, INC. (CBPO) REPORT OVERVIEW

China Biologic Products’ Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, China Biologic Products reported revenue of $112.46MM vs $91.45MM (up 22.98%) and basic earnings per share $0.93 vs $1.07 (down 13.08%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, China Biologic Products reported revenue of $370.41MM vs $341.17MM (up 8.57%) and basic earnings per share $2.40 vs $3.79 (down 36.68%). China Biologic Products is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.35. The estimated EPS forecast for the next fiscal year is $5.55 and is expected to report on February 27th, 2019.

To read the full China Biologic Products, Inc. (CBPO) report, download it here: http://Fundamental-Markets.com/register/?so=CBPO

-----------------------------------------

MERUS N.V. (MRUS) REPORT OVERVIEW

Merus N.V’s Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Merus N.V reported revenue of $4.43MM vs -$0.49MM and basic earnings per share -$0.89 vs -$2.46. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Merus N.V reported revenue of $15.37MM vs $3.01MM (up 410.90%) and basic earnings per share -$4.30 vs -$3.95. Merus N.V is expected to report earnings on July 10th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$1.23. The estimated EPS forecast for the next fiscal year is -$4.26 and is expected to report on April 25th, 2019.

To read the full Merus N.V. (MRUS) report, download it here: http://Fundamental-Markets.com/register/?so=MRUS

-----------------------------------------

ADIENT PLC (ADNT) REPORT OVERVIEW

Adient’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Adient reported revenue of $4,596.00MM vs $4,201.00MM (up 9.40%) and basic earnings per share -$1.80 vs $2.03. For the twelve months ended September 30th, 2017 vs September 30th, 2016, Adient reported revenue of $16,213.00MM vs $16,790.00MM (down 3.44%) and basic earnings per share $9.38 vs -$16.50. Adient is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $2.52. The estimated EPS forecast for the next fiscal year is $9.17 and is expected to report on November 1st, 2018.

To read the full Adient PLC (ADNT) report, download it here: http://Fundamental-Markets.com/register/?so=ADNT

-----------------------------------------

G1 THERAPEUTICS, INC. (GTHX) REPORT OVERVIEW

G1 Therapeutics’ Recent Financial Performance

G1 Therapeutics is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$1.09. The estimated EPS forecast for the next fiscal year is -$3.01 and is expected to report on February 20th, 2019.

To read the full G1 Therapeutics, Inc. (GTHX) report, download it here: http://Fundamental-Markets.com/register/?so=GTHX

-----------------------------------------

WESTPORT FUEL SYSTEMS INC. (WPRT) REPORT OVERVIEW

Westport Fuel’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Westport Fuel reported revenue of $67.60MM vs $60.02MM (up 12.62%) and basic earnings per share -$0.11 vs -$0.11. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Westport Fuel reported revenue of $247.06MM vs $177.39MM (up 39.27%) and basic earnings per share -$0.08 vs -$1.07. Westport Fuel is expected to report earnings on August 13th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.12. The estimated EPS forecast for the next fiscal year is $0.10 and is expected to report on March 28th, 2019.

To read the full Westport Fuel Systems Inc. (WPRT) report, download it here: http://Fundamental-Markets.com/register/?so=WPRT

-----------------------------------------

APPFOLIO, INC. (APPF) REPORT OVERVIEW

AppFolio’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, AppFolio reported revenue of $42.34MM vs $32.13MM (up 31.79%) and basic earnings per share $0.13 vs $0.02 (up 550.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, AppFolio reported revenue of $143.80MM vs $105.59MM (up 36.20%) and basic earnings per share $0.29 vs -$0.25. AppFolio is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $0.74 and is expected to report on February 25th, 2019.

To read the full AppFolio, Inc. (APPF) report, download it here: http://Fundamental-Markets.com/register/?so=APPF

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

AP RADIO
Update hourly